Christopher Kenney
Technik-/Wissenschafts-/F&E-Leiter bei XENON PHARMACEUTICALS INC.
Vermögen: - $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ian Mortimer | M | 48 | 11 Jahre | |
| Simon Pimstone | M | 56 | 28 Jahre | |
| Clarence Machado | M | 60 | 4 Jahre | |
| Andrea DiFabio | F | 55 | 2 Jahre | |
| Sherry Aulin | F | 41 | 13 Jahre | |
| Gary Patou | M | 65 | 20 Jahre | |
| Steven Gannon | M | 62 | 9 Jahre | |
| Elizabeth Garofalo | M | 66 | 3 Jahre | |
| Mohammad Azab | M | 68 | 21 Jahre | |
| Jodi Regts | F | - | 9 Jahre | |
| Dawn Svoronos | F | 70 | 8 Jahre | |
| Gillian Cannon | M | 60 | 1 Jahre | |
| Christopher von Seggern | M | 45 | 4 Jahre | |
| Robin Sherrington | M | 63 | 23 Jahre | |
| James Empfield | M | - | 8 Jahre | |
| Shelley McCloskey | F | 64 | 5 Jahre | |
| Sheila M. Grant | F | - | 4 Jahre | |
| Justin Gover | M | 53 | 1 Jahre | |
| Michael Rogawski | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Hayden | M | 72 | 26 Jahre | |
| Dave Grayzel | M | 56 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Catherine D. Strader | M | 70 | 4 Jahre | |
| Jodie Morrison | F | 48 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 Jahre |
| Adrian L. Rabinowicz | M | - | 6 Jahre | |
| Burkhard Blank | M | 69 | 5 Jahre | |
| Michael Rogers | M | 64 | 3 Jahre | |
| John McBride | M | 72 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 Jahre |
| Benedict Osorio | M | 67 | 2 Jahre | |
| Anthony Caggiano | M | 54 | 16 Jahre | |
| Michael Mulqueen | M | - |
Biotie Therapies, Inc.
| 4 Jahre |
| Enrique Carrazana | M | 62 | 5 Jahre | |
| Michael Samar | M | 51 | 3 Jahre | |
| Erin Campany | F | 57 | 4 Jahre | |
| Bob Dagher | M | 55 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 20 | 58,82% |
| Vereinigte Staaten | 14 | 41,18% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Christopher Kenney
- Persönliches Netzwerk
